Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | Stitcher | Email | RSS
In this episode of Coronavirus: The Truth, Jeremy Corr and Dr. Robert Pearl discuss the long list of viral enemies attacking Americans this winter. Chief among them: Covid-19, RSV and seasonal influenza, the latter of which has tallied 8.7 million cases and 78,000 hospitalizations so far (40 times higher than at this point last year).
How seriously should American take these viral threats as we approach the holiday gathering season? You’ll find this topic and all the other [time stamped] questions from today’s show here:
[00:52] Each show begins with the most recent and relevant facts concerning the Covid-19 pandemic and its impact on American life. What’s happening and what does it mean?
[02:45] Listener question: What’s the data on the new bivalent vaccine vs. the old one?
[07:48] How might researchers best communicate discrepancies in scientific data to patients? What should organizations like the CDC and WHO do?
[08:47] What’s new regarding the ‘tripledemic’ since the last episode?
[11:03] What’s happening with the flu?
[13:28] Why are Chinese citizens protesting “Zero-Covid” restrictions?
[16:28] What caused the near-global breakdown in public policy during Covid-19?
[18:53] Who are the people comprising the 300-350 deaths in the United States each day from Covid-19?
[22:50]: Kids and Covid-19: what’s new?
[25:03] What’s new in healthcare beyond Covid-19?
[26:44] How can patients help prevent the scourge of chronic disease in the United States?
[28:19] What has happened to cancer screening since the start of the pandemic?
This episode is available on Apple Podcasts, Google Play, Spotify and other podcast platforms.
If you have coronavirus questions for the hosts, please visit the contact page or send us a message on Twitter or LinkedIn.
*To ensure the credibility of this program, Coronavirus: The Truth refuses to accept sponsorship, outside funding sources or guests with any financial or personal conflicts of interest.